Salesforce Vs. Lyra Therapeutics Industry Stock Comparison

Buy

59

CRM
Salesforce

Last Price:

$269.74

Seasonality Move:

8.88%

Sell

32

LYRA
Lyra Therapeutics

Last Price:

$9.10

Seasonality Move:

-2.29%

Buy

59

Salesforce (CRM) is a Buy

Is Salesforce a Buy, Sell or Hold?

The current Salesforce [CRM] share price is $272.15. The Score for CRM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

32

Lyra Therapeutics (LYRA) is a Sell

Is Lyra Therapeutics a Buy, Sell or Hold?

The current Lyra Therapeutics [LYRA] share price is $9.00. The Score for LYRA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
LYRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRM Stock Price Chart

What is Salesforce's stock price today?

The Salesforce share price today is $272.15

The current trend is moderately bullish and CRM is experiencing slight buying pressure.

LYRA Stock Price Chart

What is Lyra Therapeutics's stock price today?

The Lyra Therapeutics share price today is $9.00

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYRA is experiencing slight selling pressure.

CRM Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.17	Buy
Relative Strength Index (14 RSI):	53.23	Buy
Chaikin Money Flow:	236955	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(262.44 - 271.48)	Buy
Bollinger Bands (100):	(256.67 - 299.17)	Sell

LYRA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.39	Sell
Relative Strength Index (14 RSI):	44.26	Sell
Chaikin Money Flow:	-16263	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(7.53 - 19.57)	Sell
Bollinger Bands (100):	(4.06 - 13.18)	Buy

CRM Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	271.13	Buy
20-day SMA:	267.63	Buy
50-day SMA:	272.03	Buy
200-day SMA:	296.46	Sell
8-day EMA:	270.22	Buy
20-day EMA:	269.03	Buy
50-day EMA:	254.96	Buy
200-day EMA:	139.4	Buy

LYRA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	10.48	Sell
20-day SMA:	12.91	Sell
50-day SMA:	9.32	Sell
200-day SMA:	9.78	Sell
8-day EMA:	10.03	Sell
20-day EMA:	11.05	Sell
50-day EMA:	10.19	Sell
200-day EMA:	21.81	Sell

Salesforce Earnings Growth & CRM Earnings Dates

Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.23 per share, an increase this year of $1.83 per share, and an increase next year of $1.26 per share.

Lyra Therapeutics Earnings Growth & LYRA Earnings Dates

Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.

Salesforce Technical Analysis

	Jun 20	Jun 23	Jun 24	Jun 25	Jun 26	Jun 27	Jun 30	Jul 1	Jul 2	Jul 3
	Jun								Jul
	20	23	24	25	26	27	30	01	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyra Therapeutics Technical Analysis

	Jun 20	Jun 23	Jun 24	Jun 25	Jun 26	Jun 27	Jun 30	Jul 1	Jul 2	Jul 3
	Jun								Jul
	20	23	24	25	26	27	30	01	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):